Thrombolysis with Low-Dose Tissue Plasminogen Activator 3–4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan-Reference-Cited by-同舟云学术

Thrombolysis with Low-Dose Tissue Plasminogen Activator 3–4.5 h After Acute Ischemic Stroke in Five Hospital Groups in Japan

Published:2016-01-27 Issue:2 Volume:7 Page:111-119
ISSN:1868-4483
Container-title:Translational Stroke Research
language:en
Short-container-title:Transl. Stroke Res.

Author:

Morihara Ryuta,Kono Syoichiro,Sato Kota,Hishikawa Nozomi,Ohta Yasuyuki,Yamashita Toru,Deguchi Kentaro,Manabe Yasuhiro,Takao Yoshiki,Kashihara Kenichi,Inoue Satoshi,Kiriyama Hideki,Abe Koji

Funder

Grants-in-Aid for Scientific Research

Grant-in-Aid for Challenging Research

Grants-in-Aid from the Research Committees (Mizusawa H, Nakano I, Nishizawa M, Sasaki H, and Aoki M)

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Clinical Neurology,General Neuroscience

Link

http://link.springer.com/content/pdf/10.1007/s12975-016-0448-8.pdf

Reference34 articles.

1. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, et al. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke. 2006;37:1810–5.

2. Wahlgren N, Ahmed N, Davalos A, Hacke W, Millan M, Muir K, et al. Thrombolysis with alteplase 3–4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet. 2008;372:1303–9.

3. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009;40:2761–2768

4. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010;375:1695–703.

5. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768–74.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment outcome of bridge mechanical thrombectomy with different IV-tPA dosages in the standard and extended time window in real-world practice;The Neuroradiology Journal;2024-08-26

2. Direct targeting of DOCK4 by miRNA-181d in oxygen-glucose deprivation/reoxygenation-mediated neuronal injury;Lipids in Health and Disease;2023-03-07

3. Effect of plasma thrombin-antithrombin complex on ischemic stroke: a systematic review and meta-analysis;Systematic Reviews;2023-02-14

4. Electroacupuncture attenuates ischemic injury after stroke and promotes angiogenesis via activation of EPO mediated Src and VEGF signaling pathways;PLOS ONE;2022-09-15

5. Association Between Oral Anticoagulants and Stroke Severity at Onset in Elderly Patients with Cardioembolic Stroke Due to Non-Valvular Atrial Fibrillation;Journal of Stroke and Cerebrovascular Diseases;2022-03